135 related articles for article (PubMed ID: 25167990)
1. Novel bladder preservation therapy with Osaka Medical College regimen.
Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
J Urol; 2015 Feb; 193(2):443-50. PubMed ID: 25167990
[TBL] [Abstract][Full Text] [Related]
2. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
Int J Oncol; 2010 Oct; 37(4):773-85. PubMed ID: 20811698
[TBL] [Abstract][Full Text] [Related]
3. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
4. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen).
Azuma H; Inamoto T; Takahara K; Nomi H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Yamamoto K; Narumi Y; Kiyama S
Int J Oncol; 2013 Jul; 43(1):79-87. PubMed ID: 23624911
[TBL] [Abstract][Full Text] [Related]
6. Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.
Azuma H; Inamoto T; Ibuki N; Ubai T; Kotake Y; Takahara K; Kiyama S; Nomi H; Uehara H; Komura K; Yamamoto K; Narumi Y; Katsuoka Y
Int J Oncol; 2011 Jan; 38(1):13-24. PubMed ID: 21109921
[TBL] [Abstract][Full Text] [Related]
7. Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.
Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Komura K; Uehara H; Minami K; Yamamoto K; Narumi Y
Int J Oncol; 2019 Jan; 54(1):167-176. PubMed ID: 30387836
[TBL] [Abstract][Full Text] [Related]
8. A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen).
Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Uehara H; Komura K; Minami K; Kouno J; Kotake Y; Abe H; Takagi S; Ibuki N; Yamamoto K; Narumi Y; Kiyama S
Int J Oncol; 2013 Oct; 43(4):1087-94. PubMed ID: 23934264
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
Zargar H; Shah JB; van Rhijn BW; Daneshmand S; Bivalacqua TJ; Spiess PE; Black PC; Kassouf W;
J Urol; 2018 Jun; 199(6):1452-1458. PubMed ID: 29329894
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.
Azuma H; Inamoto T; Takahara K; Ibuki N; Nomi H; Yamamoto K; Narumi Y; Ubai T
Int J Urol; 2012 Jan; 19(1):26-38. PubMed ID: 22077821
[TBL] [Abstract][Full Text] [Related]
13. Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer.
Cobo M; Delgado R; Gil S; Herruzo I; Baena V; Carabante F; Moreno P; Ruiz JL; Bretón JJ; Del Rosal JM; Fuentes C; Moreno P; García E; Villar E; Contreras J; Alés I; Benavides M
Clin Transl Oncol; 2006 Dec; 8(12):903-11. PubMed ID: 17169764
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer.
Nakata M; Shimbo T; Kihara A; Sato C; Hori A; Yoshioka H; Yoshida K; Nihei K
Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):e430-e436. PubMed ID: 35715341
[TBL] [Abstract][Full Text] [Related]
15. The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer.
Liu Z; Ye Y; Li X; Guo S; Jiang L; Dong P; Li Y; Shi Y; Fan W; Cao Y; Yao K; Qin Z; Han H; Zhou F; Liu Z
World J Urol; 2018 Aug; 36(8):1191-1200. PubMed ID: 29459997
[TBL] [Abstract][Full Text] [Related]
16. An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
Feng YH; Shen KH; Huang KH; Tzeng WS; Li CF; Lin KL
Clin Genitourin Cancer; 2016 Feb; 14(1):e67-74. PubMed ID: 26428609
[TBL] [Abstract][Full Text] [Related]
17. Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial.
Azria D; Riou O; Rebillard X; Thezenas S; Thuret R; Fenoglietto P; Pouessel D; Culine S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):853-9. PubMed ID: 24368064
[TBL] [Abstract][Full Text] [Related]
18. Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Rose TL; Harrison MR; Deal AM; Ramalingam S; Whang YE; Brower B; Dunn M; Osterman CK; Heiling HM; Bjurlin MA; Smith AB; Nielsen ME; Tan HJ; Wallen E; Woods ME; George D; Zhang T; Drier A; Kim WY; Milowsky MI
J Clin Oncol; 2021 Oct; 39(28):3140-3148. PubMed ID: 34428076
[TBL] [Abstract][Full Text] [Related]
19. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer.
Eapen L; Stewart D; Collins J; Peterson R
J Urol; 2004 Oct; 172(4 Pt 1):1276-80. PubMed ID: 15371823
[TBL] [Abstract][Full Text] [Related]
20. Treatment Results of Radiotherapy Combined with Balloon-occluded Arterial Infusion Chemotherapy for Invasive Bladder Cancer.
Yoshioka H; Shimbo T; Yoshida K; Yoshikawa N; Uesugi Y; Yamamoto K; Azuma H; Narumi Y
Anticancer Res; 2016 Feb; 36(2):731-6. PubMed ID: 26851031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
